Northfield on Life Support With FDA Ruling

(Crain’s) — Shares of Northfield Laboratories Inc. plummeted Friday, a day after the firm disclosed that federal regulators rejected its experimental blood substitute. The U.S. Food and Drug Administration said data for the product, Polyheme, showed that it “places the patients at a ...

Copyright CRAIN - Crain's
Contact Us